Fed. Circ. Won't Review Inherently Obvious Patent Standard
The full Federal Circuit on Friday denied a petition by Hospira Inc. to weigh in on when patents can be invalidated as inherently obvious, part of the Pfizer unit's fight with...To view the full article, register now.
Already a subscriber? Click here to view full article